Bank of Montreal
SBBP

Bank of Montreal’s Strongbridge Biopharma plc. SBBP Stock Holding History

Bank of Montreal’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-399,192
Closed -$1.2M – 4032
2021
Q2 		$1.2M Buy
399,192
+198,875
+99% +$525K ﹤0.01% 2368
2021
Q1 		$537K Sell
200,317
-62,179
-24% -$188K ﹤0.01% 2598
2020
Q4 		$802K Buy
262,496
+86,293
+49% +$208K ﹤0.01% 2392
2020
Q3 		$378K Buy
176,203
+172,622
+4,820% +$582K ﹤0.01% 2453
2020
Q2 		$13K Buy
3,581
+2,217
+163% +$6.64K ﹤0.01% 4063
2020
Q1 		$3K Sell
1,364
-65,122
-98% -$169K ﹤0.01% 3819
2019
Q4 		$139K Buy
66,486
+62,390
+1,523% +$120K ﹤0.01% 3354
2019
Q3 		$10K Buy
4,096
+1,075
+36% +$2.89K ﹤0.01% 4437
2019
Q2 		$9K Buy
+3,021
New +$11.1K ﹤0.01% 4580

Other funds holding SBBP

CC
Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Bank of Montreal's SBBP Position: Q3 2021 in Review

Bank of Montreal sold out of Strongbridge Biopharma plc. (SBBP) in Q3 2021, closing a stake of 399,192 shares — an estimated $1.2M sold.

Bank of Montreal first reported a position in SBBP in Q2 2019 and held it in 9 quarters. The position peaked at $1.2M in Q2 2021. 49 funds tracked by Wall St. Rank hold SBBP as of Q3 2021.

  • Bank of Montreal reported no remaining Strongbridge Biopharma plc. position as of Q3 2021 after selling out during the quarter.
  • Bank of Montreal sold 399,192 Strongbridge Biopharma plc. shares in Q3 2021, an estimated $1.2M.
  • Bank of Montreal first reported a position in Strongbridge Biopharma plc. in Q2 2019 and held it in 9 quarters.
  • Bank of Montreal's Strongbridge Biopharma plc. position peaked at $1.2M in Q2 2021.
  • 49 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q3 2021.

Based on Bank of Montreal's 13F filing for Q3 2021, filed 12 Nov 2021.